Hideko Kozuru
Omura, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
On-Treatment Reassessment of Type IV Collagen 7S and M2BPGi-Qt Improves Long-Term Hepatocellular Carcinoma Risk Stratification in Chronic Hepatitis B.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: June 24, 2026
Changes in serum myostatin levels among patients with type C liver cirrhosis treated with direct-acting antivirals.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: July 19, 2024
Uric acid-mediated inflammasome activation in IL-6 primed innate immune cells is regulated by baricitinib.
Journal: Modern rheumatology
Published: March 10, 2020
JAK inhibitors impair GM-CSF-mediated signaling in innate immune cells.
Journal: BMC immunology
Published: March 08, 2020
Galectin-9 as a biomarker for disease activity in systemic lupus erythematosus.
Journal: PloS one
Published: September 29, 2019
Galectin-9 in autoimmune hepatitis: Correlation between serum levels of galectin-9 and M2BPGi in patients with autoimmune hepatitis.
Journal: Medicine
Published: August 30, 2019
Hydroxychloroquine inhibits IL-1β production from amyloid-stimulated human neutrophils.
Journal: Arthritis research & therapy
Published: May 26, 2019
Tofacitinib inhibits granulocyte-macrophage colony-stimulating factor-induced NLRP3 inflammasome activation in human neutrophils.
Journal: Arthritis research & therapy
Published: December 01, 2017
TNF-α potentiates uric acid-induced interleukin-1β (IL-1β) secretion in human neutrophils.
Journal: Modern rheumatology
Published: September 08, 2017
The 23-valent pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis: a double-blinded, randomized, placebo-controlled trial.
Journal: Arthritis research & therapy
Published: May 26, 2016
Last Updated: 09/26/2026